 BUFFALO, N.Y., April 27, 2021 GLOBE NEWSWIRE -- Athenex, Inc., NASDAQ: ATNX, a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the Company will provide a corporate and financial update for the first quarter 2021, on Thursday, May 6, 2021, before the market opens. Athenexs management team will host a conference call and live audio webcast at 8:00 am Eastern Time. 